Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

Obesity drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) traded higher in the premarket on Friday after The Washington ...

Medicare Advantage, the privately run insurance on which roughly 500,000 older Louisiana residents rely for health care, is ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

In letters posted on Truth Social, Trump demanded that drugmakers offer their medications at the same prices paid abroad.

Trump's reviving an outdated and problematic American practice in the Presidential Fitness Test in a fitting MAGA move.

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.